Published in Horm Metab Res on October 01, 1992
Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices. J Diabetes Sci Technol (2007) 1.28
Microdialysis as a tool in local pharmacodynamics. AAPS J (2006) 0.78
Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes (2006) 2.28
Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest (1989) 2.25
CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab (1997) 1.78
Glucocorticoids and insulin promote the differentiation of human adipocyte precursor cells into fat cells. J Clin Endocrinol Metab (1987) 1.78
Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res (2000) 1.71
The influence of insulin antibodies on the pharmacokinetics of NPH insulin in patients with type 1 diabetes treated with human insulin. Diabet Med (1995) 1.40
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity (2000) 1.40
The pipsqueak protein of Drosophila melanogaster binds to GAGA sequences through a novel DNA-binding domain. J Biol Chem (1998) 1.29
The artificial beta cell--a continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res (1974) 1.28
Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes (1997) 1.26
Does fall in tissue glucose precede fall in blood glucose? Diabetologia (1996) 1.26
Diabetic retinopathy in type 1 diabetes-a contemporary analysis of 8,784 patients. Diabetologia (2011) 1.25
A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene. Diabet Med (1998) 1.21
Differentiation of adipocyte precursor cells from obese and nonobese adult women and from different adipose tissue sites. Horm Metab Res Suppl (1988) 1.19
Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man. Horm Metab Res (1976) 1.14
Hypergastrinemia induced by glucocorticoid and corticotropin treatment in man. Am J Dig Dis (1976) 1.09
Spatially varying properties of the vocal ligament contribute to its eigenfrequency response. J Mech Behav Biomed Mater (2010) 1.07
Action of streptozotocin on insulin and glucagon responses of rat islets. Horm Metab Res (1970) 1.06
Effects of somatostatin on gastric secretion and gastrin release in man. Digestion (1975) 1.05
Gastrin concentration in plasma of the neonate at birth and after the first feeding. Pediatrics (1976) 1.04
Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans. J Clin Endocrinol Metab (2000) 1.03
[Direct stimulation of insulin secretion in vitro by scretion]. Dtsch Med Wochenschr (1965) 1.03
Action of B-hydroxy butyrate, acetoacetate and palmitate on the insulin release in the perfused isolated rat pancreas. Horm Metab Res (1974) 1.00
Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fundam Clin Pharmacol (2001) 1.00
Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs. Regul Pept (1980) 0.98
CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis. Tissue Antigens (1998) 0.98
The UK Prospective Diabetes Study. Lancet (1998) 0.98
[Resynthesis of insulin from the preoxidized A chain and reduced B chain]. Justus Liebigs Ann Chem (1966) 0.97
Subcutaneous glucose concentration in humans. Real estimation and continuous monitoring. Diabetes Care (1995) 0.97
Maculopathy in patients with diabetes mellitus type 1 and type 2: associations with risk factors. Br J Ophthalmol (2000) 0.96
Differential and integral corticosteroid feedback effects on ACTH secretion in hypoadrenocorticism. J Clin Invest (1979) 0.95
Acute hypothyroidism slows the rate of left ventricular diastolic relaxation. Can J Physiol Pharmacol (1989) 0.94
Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes. Ann Nutr Metab (1988) 0.92
Paradoxical ACTH response to glucocorticoids in Cushing's disease. N Engl J Med (1977) 0.92
Differences in exhaled gas profiles between patients with type 2 diabetes and healthy controls. Diabetes Technol Ther (2010) 0.92
Differential effects of human and pork insulin-induced hypoglycemia on neuronal functions in humans. Diabetes (1990) 0.91
Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas. Horm Metab Res (1971) 0.91
Multiple complications and frequent severe hypoglycaemia in 'elderly' and 'old' patients with Type 1 diabetes. Diabet Med (2012) 0.91
Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med (2000) 0.90
Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. Endocrinology (1990) 0.90
Stimulation of H-3-leucine incorporation into the proinsulin and insulin fraction of isolated pancreatic mouse islets in the presence of glucagon, theophylline and cyclic AMP. Diabetes (1973) 0.89
Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans. J Clin Endocrinol Metab (1999) 0.89
[Metabolic changes in zero-diet]. Internist (Berl) (1970) 0.89
[The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)]. MMW Munch Med Wochenschr (1976) 0.89
Amperometric biosensor for in vivo glucose sensing based on glucose oxidase immobilized in a redox hydrogel. Biosens Bioelectron (1994) 0.89
[Reversible germ cell toxicity following aggressive chemotherapy in patients with testicular tumors: results of a prospective study]. Klin Wochenschr (1989) 0.88
On line continuous monitoring of subcutaneous tissue glucose in men by combining portable glucosensor with microdialysis. Diabetologia (1992) 0.88
On line continuous monitoring of subcutaneous tissue glucose is feasible by combining portable glucosensor with microdialysis. Horm Metab Res (1993) 0.88
Insulin therapy in relation to circulating C-peptide levels. Diabetes (1978) 0.88
Somatostatin: a potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Klin Wochenschr (1976) 0.87
The effect of serotonin on in vitro insulin secretion and biosynthesis in mice. Diabetologia (1974) 0.87
Role of the vasoactive intestinal peptide in a neuroendocrine regulation of the adrenal cortex. Neuroendocrinology (1991) 0.86
Association between depression and subclinical carotid atherosclerosis in patients with Type 1 diabetes. Diabet Med (2008) 0.85
Fetal hemoglobin in starvation ketosis of young women. Blood (1998) 0.85
Glucose concentration in human subcutaneous adipose tissue: comparison between forearm and abdomen. Exp Clin Endocrinol Diabetes (1998) 0.85
Biosynthetic human insulin: progress and prospects. Diabetes Care (1981) 0.85
The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human sub-cutaneous tissue and plasma. Biosens Bioelectron (1993) 0.85
Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin. Metabolism (1978) 0.85
Dilatory and inotropic effects of corticotropin-releasing factor (CRF) on the isolated heart. Effects on atrial natriuretic peptide (ANP) release. Horm Metab Res (1992) 0.85
Inhibition of cholecystokinin-pancreozymin release by somatostatin. Lancet (1977) 0.85
On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future. XII Congress of the International Diabetes Federation, Madrid, 22-28 September 1985. Diabetologia (1987) 0.84
Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus. Digestion (2013) 0.83
Does insulin play a role in the regulation of its own secretion? Horm Metab Res (1978) 0.83
Symptom awareness is affected by the subjects' expectations during insulin-induced hypoglycemia. Diabetes Care (1997) 0.83
The influence of circulating thyroxine serum concentration on hepatic thyroxine deiodinating activity in rats. Exp Clin Endocrinol (1990) 0.83
[On the regulation of nonesterified fatty acids with special reference to prostaglandins]. Dtsch Med Wochenschr (1966) 0.83
(Pro-) insulin biosynthesis and release of newly synthesized (pro-) insulin from isolated islets of rat pancreas in the presence of amino acids and sulphonylureas. Eur J Clin Invest (1975) 0.83
CTLA4 gene haplotypes cannot protect from IDDM in the presence of high-risk HLA DQ8 or DQ2 alleles in German families. Diabetes (1998) 0.83
Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring. Diabetes Care (1985) 0.83
Effects of neurotransmitters on the release of corticotropin releasing hormone (CRH) by rat hypothalamic tissue in vitro. Exp Brain Res (1980) 0.83
Studies on juvenile--type diabetes in children. Assessment of control under treatment with constant and variable doses of insulin with or without addition of biguanides. Diabete Metab (1975) 0.83
Primary secretion of insulin and secondary release of glucagon from the isolated perfused rat pancreas following stimulation with pancreozymin. Horm Metab Res (1969) 0.82
Optimized postprandial glucose control is associated with improved cardiac/vascular function - comparison of three insulin regimens in well-controlled type 2 diabetes. Horm Metab Res (2009) 0.82
Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell. Horm Metab Res (1976) 0.82
Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism. Metabolism (1988) 0.82
Hyperglucagonemia of the isolated perfused pancreas of diabetic mice (db-db). Diabetologia (1973) 0.82
Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia (1983) 0.82
Isolation of IgG islet cell autoantibody-producing B lymphocytes from the peripheral blood of type 1 diabetic patients and an ICA-positive non-diabetic individual. Horm Metab Res (1989) 0.82
Comparison of the biologic activity of biosynthetic human insulin and natural pork insulin in juvenile-onset diabetic subjects assessed by the glucose controlled insulin infusion system. Diabetes Care (1981) 0.81
Long-term experiences with a computerized diabetes management and glucose monitoring system in insulin-dependent diabetic patients. Diabetes Res Clin Pract (1994) 0.81
Problems and artefacts in ACTH assay. Horm Metab Res (1972) 0.81
Histometric investigations on the testicular tissue of rats with alloxan diabetes and Chinese hamsters with spontaneous diabetes. Acta Endocrinol (Copenh) (1967) 0.81
Somatostatin modulation of pancreatic glucagon, insulin, glucose and free fatty acids following beta-adrenergic stimulation. J Clin Endocrinol Metab (1977) 0.81
Growth hormone radiologand assay unresponsive to human prolactin. J Clin Endocrinol Metab (1976) 0.81
Spontaneous and stimulated secretion of QUSO-extractable immunoassayable ACTH in man. Klin Wochenschr (1974) 0.81